What is the recommended dosage of cefotaxime (Cefotaxime) administered intravenously (IV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Cefotaxime IV Dosage

The standard recommended dosage of cefotaxime for adults is 2 grams administered intravenously every 6-8 hours, with a maximum daily dose of 12 grams. 1

Adult Dosing Guidelines

General Infections

  • Uncomplicated infections: 2 g daily (1 g every 12 hours) IV 1
  • Moderate to severe infections: 3-6 g daily (1-2 g every 8 hours) IV 1
  • Septicemia: 6-8 g daily (2 g every 6-8 hours) IV 1
  • Life-threatening infections: Up to 12 g daily (2 g every 4 hours) IV 1

Specific Conditions

  • Bacterial meningitis: 2 g every 6 hours IV 2
  • Spontaneous bacterial peritonitis: 2 g every 8 hours IV 2
    • 5-day treatment has shown similar efficacy to 10-day treatment for SBP 2
  • Gram-negative enteric bacilli infections: 200 mg/kg/day IV divided every 6 hours (up to 12 g daily) 2

Pediatric Dosing

  • Neonates (0-1 week): 50 mg/kg every 12 hours IV 1
  • Neonates (1-4 weeks): 50 mg/kg every 8 hours IV 1
  • Infants and children (1 month to 12 years):
    • 50-180 mg/kg/day IV divided into 4-6 doses 1
    • Higher dosages (up to 180 mg/kg/day) for severe infections including meningitis 1
    • Alternative regimen: 75 mg/kg every 8 hours or 100 mg/kg/day as twice daily dosing has shown efficacy in pediatric lower respiratory infections 3, 4

Special Populations

Elderly Patients

  • Dose adjustment may be necessary due to decreased renal function 1
  • Monitor renal function closely in elderly patients 1

Renal Impairment

  • Dosage adjustment required based on creatinine clearance 1
  • For patients with severe renal impairment, consider extending dosing interval rather than reducing individual doses 5

Duration of Therapy

  • General infections: Minimum 48-72 hours after patient defervesces or evidence of bacterial eradication 1
  • Meningococcal meningitis: 5 days if clinical recovery has occurred 2, 6
  • Pneumococcal meningitis: 10 days if stable, up to 14 days if slower to respond 2, 6
  • Spontaneous bacterial peritonitis: 5-10 days, with 5 days showing similar efficacy to 10 days 2
  • Group A beta-hemolytic streptococcal infections: Minimum 10 days to prevent rheumatic fever or glomerulonephritis 1

Clinical Pearls and Caveats

  • Twice-daily dosing (2 g every 12 hours) has shown similar efficacy to once-daily ceftriaxone for serious infections outside the ICU setting 7, 8
  • For hospital-acquired spontaneous bacterial peritonitis, consider the risk of extended-spectrum beta-lactamase (ESBL)-producing bacteria, which may be resistant to third-generation cephalosporins 2
  • Cefotaxime penetrates well into ascitic fluid, with 20-fold killing power after one dose 2
  • Adjust therapy based on culture and sensitivity results when available
  • In patients with normal renal function, cefotaxime 1-2 g every 12 hours should be effective against organisms with MICs <0.5 μg/ml 5

Remember that cefotaxime should be administered for a minimum of 48-72 hours after the patient defervesces or after evidence of bacterial eradication has been obtained 1. Always consider local resistance patterns when selecting empiric antibiotic therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.